Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.
Schrödinger takes a step forward with AlphaFold in drug R&D, as biotech hits a pipeline ‘inflection’
Schrödinger has workshopped a fix for one of the biggest problems with AlphaFold-generated protein structure predictions, in what the company is describing as a notable